ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

RPRX Royalty Pharma PLC

26.89
-0.295 (-1.09%)
Jun 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Royalty Pharma PLC RPRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.295 -1.09% 26.89 23:00:07
Open Price Low Price High Price Close Price Previous Close
27.15 26.705 27.20 26.92 27.185
more quote information »

Recent News

Date Time Source Heading
6/10/202415:58EDGAR2Form 8-K - Current report
6/06/202416:06EDGAR2Form 8-K - Current report
6/04/202416:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
6/04/202415:57EDGAR2Form 8-K - Current report
6/04/202415:15GLOBERoyalty Pharma to Present at the Goldman Sachs 45th Annual..
6/03/202416:15GLOBERoyalty Pharma Announces Pricing of $1.5 Billion of Senior..
6/03/202415:59EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
6/03/202408:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
6/03/202407:39EDGAR2Form S-3ASR - Automatic shelf registration statement of..
5/29/202416:25EDGAR2Form 8-K - Current report
5/28/202406:10GLOBERoyalty Pharma and Agios Pharmaceuticals Enter Into..
5/22/202415:10GLOBERoyalty Pharma and Cytokinetics Announce Expanded Strategic..
5/22/202415:00GLOBECytokinetics and Royalty Pharma Announce Expanded Strategic..
5/16/202416:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/13/202407:15GLOBERoyalty Pharma to Present at Upcoming Investor Conferences
5/09/202408:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202406:17EDGAR2Form 8-K - Current report
5/09/202406:00GLOBERoyalty Pharma Reports First Quarter 2024 Results
5/09/202405:45GLOBERoyalty Pharma to Acquire Royalty Interest in Sanofi’s..
4/19/202407:15GLOBERoyalty Pharma to Announce First Quarter 2024 Financial..
4/17/202407:15GLOBERoyalty Pharma Declares Second Quarter 2024 Dividend
2/28/202415:15GLOBERoyalty Pharma to Present at TD Cowen’s 44th Annual Health..
2/15/202408:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/15/202406:33EDGAR2Form 8-K - Current report
2/15/202406:30GLOBERoyalty Pharma Reports Q4 and Full Year 2023 Results
2/06/202406:01EDGAR2Form 8-K - Current report
1/30/202415:15GLOBERoyalty Pharma To Announce Fourth Quarter And Full Year 2023..
1/19/202407:15GLOBERoyalty Pharma Announces Dividend Increase
1/08/202406:18EDGAR2Form 8-K - Current report
1/08/202406:00GLOBERoyalty Pharma Highlights Accomplishments and Provides..
1/03/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202415:30EDGAR2Form 144 - Report of proposed sale of securities
12/29/202315:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202315:31EDGAR2Form 8-K - Current report
12/27/202312:05EDGAR2Form 8-K - Current report
12/19/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/13/202315:47EDGAR2Form 144 - Report of proposed sale of securities
11/27/202315:15GLOBERoyalty Pharma to Present at the Evercore ISI 6th Annual..
11/16/202316:16EDGAR2Form 8-K - Current report
11/16/202316:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/14/202318:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202307:10GLOBERoyalty Pharma and Teva Collaborate to Further Accelerate..
11/13/202307:00BWTeva and Royalty Pharma Collaborate to Further Accelerate..
11/08/202308:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202306:40EDGAR2Form 8-K - Current report
11/08/202306:00GLOBERoyalty Pharma Reports Third Quarter 2023 Results
10/19/202308:29EDGAR2Form 8-K - Current report
10/19/202306:59GLOBERoyalty Pharma Announces Agreement to Purchase Up to $1.5..
10/16/202315:15GLOBERoyalty Pharma Declares Fourth Quarter 2023 Dividend